Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Colorimetric Evaluation of the Time-Killing Assay for Citropin 1.1, Lipopeptide Palm-KK-$NH_2$, and Temporin A

  • Baranska-Rybak, Wioletta (Department of Dermatology, Venerology and Allergology, Faculty of Medicine, Medical University of Gdansk) ;
  • Dawgul, Malgorzata (Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdansk) ;
  • Bielinska, Sylwia (Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdansk) ;
  • Kraska, Bartlomiej (Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdansk) ;
  • Piechowicz, Lidia (Department of Microbiology, Faculty of Medicine, Medical University of Gdansk) ;
  • Kamysz, Wojciech (Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdansk)
  • Received : 2010.10.06
  • Accepted : 2011.03.10
  • Published : 2011.05.28
Download PDF
⟨ Previous Next ⟩

Abstract

Nowadays, there are a number of colorimetric techniques available for the determination of a time killing assay in a manner much easier and faster than those previously more commonly used, which were much more time-consuming and laborious colony counting procedures. Here, an attempt has been made to test the antimicrobial peptides of Citropin 1.1, Palm-KK-$NH_2$, and Temporin A on a reference strain of Staphylococcus aureus using resazurin as the cell viability reagent. Staphylococcus aureus was exposed to the test compounds over varying periods of time and the metabolic activity measured, with a profile of antimicrobial activity then established. The results are in agreement with data from previous literature, thus confirming the relevance of the application of resazurin for the testing of antimicrobial agents.

Keywords

References

  1. Barlos, K., O. Chatzi, D. Gatos, and G. Stavropoulos. 1991. 2- Chlorotrityl chloride resin. Studies on anchoring of Fmoc-amino acids and peptide cleavage. Int. J. Pept. Protein Res. 37: 513-520.
  2. Boland, M. P. and F. Separovic. 2006. Membrane interactions of antimicrobial peptides from Australian tree frogs. Biochim. Biophys. Acta 1758: 1178-1183. https://doi.org/10.1016/j.bbamem.2006.02.010
  3. Bulet, P., R. Stöcklin, and L. Menin. 2004. Anti-microbial peptides: From invertebrates to vertebrates. Immunol. Rev. 198: 169-184. https://doi.org/10.1111/j.0105-2896.2004.0124.x
  4. De Smet, K. and R. Contreras. 2005. Human antimicrobial peptides: Defensins, cathelicidins and histatins. Biotechnol. Lett. 27: 1337-1347. https://doi.org/10.1007/s10529-005-0936-5
  5. Fields, G. B. and R. L. Noble. 1990. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acides. Int. J. Pept. Protein Res. 35: 161-214.
  6. French, G. L. 2006. Bactericidal agents in the treatment of MRSA infections - the potential role of daptomycin. J. Antimicrob. Chemother. 58: 1107-1117. https://doi.org/10.1093/jac/dkl393
  7. Gee, T., R. Ellis, G. Marshall, J. Andrews, J. Ashby, and R. Wise. 2001. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses. Antimicrob. Agents Chemother. 45: 1843-1846. https://doi.org/10.1128/AAC.45.6.1843-1846.2001
  8. Ghiselli, R., A. Giacometti, O. Cirioni, F. Mocchegiani, C. Viticchi, G. Scalise, and V. Saba. 2002. Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. J. Surg. Res. 108: 107-111. https://doi.org/10.1006/jsre.2002.6518
  9. Giacometti, A., O. Cirioni, W. Kamysz, C. Silverstri, A. Licci, A. Riva, J. Lukasiak, and G. Scalise. 2005. In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. Peptides 26: 2111-2116. https://doi.org/10.1016/j.peptides.2005.03.009
  10. Guaní-Guerra, E., T. Santos-Mendoza, S. O. Lugo-Reyes, and L. M. Terán. 2010. Antimicrobial peptides: General overview and clinical implications in human health and disease. Clin. Immunol. 135: 1-11. https://doi.org/10.1016/j.clim.2009.12.004
  11. Guerin, T. F., M. Mondido, B. McClenn, and B. Peasley. 2001. Application of resazurin for estimating abundance of conrtaminantdegrading microorganism. Lett. Appl. Microbiol. 32: 340-345. https://doi.org/10.1046/j.1472-765X.2001.00916.x
  12. Hanberger, H., L. E. Nilsson, R. Maller, and B. Isaksson. 1991. Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of $Ca^{2+}$ and albumin on these drugs. Antimicrob. Agents Chemother. 35: 1710-1716. https://doi.org/10.1128/AAC.35.9.1710
  13. Hancock, R. E. W. and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43: 1317-1323.
  14. Hancock, R. E. W. 1997. Peptides antibiotics. Lancet 349: 418-422. https://doi.org/10.1016/S0140-6736(97)80051-7
  15. Hyatt, J. M., D. E. Nix, and J. J. Schentag. 1994. Pharmacokinetic and pharmacodynamic activites of ciprofloxacin against strains of Streptococcus pneumonia, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar. Antimicrob. Agents Chemother. 38: 2730-2737. https://doi.org/10.1128/AAC.38.12.2730
  16. Kamysz, W. 2005. Are antimicrobial peptides an alternative for conventional antibiotics? Nucl. Med. Rev. 8: 78-86.
  17. Kamysz, W., C. Silverstri, O. Cirioni, A. Giacometti, A. Licci, A. Della Vittoria, M. Okroj, and G. Scalise. 2007. In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH2 and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant Gram-positive cocci. Antimicrob. Agents Chemother. 51: 354-358. https://doi.org/10.1128/AAC.00344-06
  18. Kuper, K. M., D. M. Boles, J. F. Mohr, and A. Wanger. 2009. Antimicrobial suspectibility testing: A primer for clinicians. Pharmacotherapy 29: 1326-1343. https://doi.org/10.1592/phco.29.11.1326
  19. Levison, M. E. 2000. Pharmacodynamics of antibacterial drugs. Infect. Dis. Clin. North Am. 14: 281-291. https://doi.org/10.1016/S0891-5520(05)70248-8
  20. Levison, M. E. and J. H. Levison. 2009. Pharmacokinetics and pharmacodynamics of antibacterial drugs. Infect. Dis. Clin. North Am. 23: 791-815. https://doi.org/10.1016/j.idc.2009.06.008
  21. Stevens, D. L., B. Dotter, and K. Madaras-Kelly. 2004. A review of linezolid: The first oxazolidinone antibiotic. Expert Rev. Anti Infect. Ther. 2: 51-59. https://doi.org/10.1586/14787210.2.1.51
  22. Stewart, J. M and J. D. Young. 1984. Solid Phase Peptide Synthesi, 2nd Ed. Pierce Chemical Company, Rockford, IL USA.

Cited by

  1. Activity of short lipopeptides and conventional antimicrobials against planktonic cells and biofilms formed by clinical strains of Staphylococcus aureus vol.4, pp.12, 2011, https://doi.org/10.4155/fmc.12.100
  2. Identification and characterization of novel cecropins from the Oxysternon conspicillatum neotropic dung beetle vol.12, pp.11, 2011, https://doi.org/10.1371/journal.pone.0187914